Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

被引：0
|
作者：
Moa Lugner
Naveed Sattar
Mervete Miftaraj
Jan Ekelund
Stefan Franzén
Ann-Marie Svensson
Björn Eliasson
机构：
[1] University of Gothenburg,Institute of Medicine
[2] Sahlgrenska University Hospital,Institute of Cardiovascular and Medical Sciences
[3] University of Glasgow,undefined
[4] National Diabetes Register,undefined
[5] Centre of Registers,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Type 2 diabetes; Epidemiology; Sodium glucose transporter 2 inhibitors; Glucagon‐like peptide-1 receptor agonist; Mortality; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Socioeconomic dispartities in the use of SGLT-2 inhibitors and GLP-1 receptor antagonists in adults with type 2 diabetes in Germany
    Auzanneau, M.
    Seufert, J.
    Zimny, S.
    Haak, T.
    Zeyfang, A.
    Hugenberg, I.
    Pavel, M.
    Rosenbauer, J.
    Holl, R. W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S74 - S74
  • [42] Lipid Profile Changes Associated with SGLT-2 Inhibitors and GLP-1 Agonists in Diabetes and Metabolic Syndrome
    Premji, Resmi
    Nylen, Eric S.
    Naser, Nejat
    Gandhi, Shruti
    Burman, Kenneth D.
    Sen, Sabyasachi
    METABOLIC SYNDROME AND RELATED DISORDERS, 2022, 20 (06) : 321 - 328
  • [43] Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
    Kutz, Alexander
    Kim, Dae Hyun
    Wexler, Deborah J.
    Liu, Jun
    Schneeweiss, Sebastian
    Glynn, Robert J.
    Patorno, Elisabetta
    DIABETES CARE, 2023, 46 (11) : 2004 - 2014
  • [44] Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study
    Edwards, Khary
    Li, Xilong
    Lingvay, Ildiko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (04): : 920 - 930
  • [45] Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
    Rodriguez, Luis A.
    Finertie, Holly
    Neugebauer, Romain S.
    Gosiker, Bennett
    Thomas, Tainayah W.
    Karter, Andrew J.
    Gilliam, Lisa K.
    Oshiro, Caryn
    An, Jaejin
    Simonson, Gregg
    Cassidy-Bushrow, Andrea E.
    Dombrowski, Sarah
    Nolan, Margaret
    O'Connor, Patrick J.
    Schmittdiel, Julie A.
    LANCET REGIONAL HEALTH-AMERICAS, 2024, 34
  • [46] Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes
    Edmonston, Daniel
    Mulder, Hillary
    Lydon, Elizabeth
    Chiswell, Karen
    Lampron, Zachary
    Shay, Christina
    Marsolo, Keith
    Shah, Raj C.
    Jones, W. Schuyler
    Gordon, Howard
    Hwang, Wenke
    Ayoub, Isabella
    Ford, Daniel
    Chamberlain, Alanna
    Rao, Ajaykumar
    Fonseca, Vivian
    Chang, Alexander
    Ahmad, Faraz
    Hung, Adriana
    Hunt, Kelly
    Butler, Javed
    Bosworth, Hayden B.
    Pagidipati, Neha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (08) : 696 - 708
  • [47] Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review
    Gonzalez-Gonzalez, Jose Gerardo
    Diaz Gonzalez-Colmenero, Alejandro
    Millan-Alanis, Juan Manuel
    Lytvyn, Lyubov
    Solis, Ricardo Cesar
    Mustafa, Reem A.
    Palmer, Suetonia C.
    Li, Sheyu
    Hao, Qiukui
    Alvarez-Villalobos, Neri Alejandro
    Vandvik, Per Olav
    Rodriguez-Gutierrez, Rene
    BMJ OPEN, 2021, 11 (07):
  • [48] Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes
    Lajara, Rosemarie
    POSTGRADUATE MEDICINE, 2019, 131 (08) : 555 - 565
  • [49] Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors
    Egan, Aoife M.
    Montori, Victor M.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (02) : JC2 - JC2
  • [50] Impact of GLP-1 receptor agonists versus SGLT-2 inhibitors on diabetic retinopathy
    Joo, Julia
    Sharma, Neha
    Daugirdas, Sarunas
    Wu, Anna K.
    Russell, Matthew W.
    Skugor, Mario
    Singh, Rishi
    Rachitskaya, Aleksandra V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345